About Vibeke Strand, M.D.
Form D filings for Urica Therapeutics in 2023 list Vibeke Strand, M.D. as director.
Vibeke Strand, M.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vibeke Strand, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vibeke Strand, M.D. works with at each company, as listed on that company's latest Form D.
Urica Therapeutics, Inc. · Form D, Jan 5, 2023
RZ
Raymond Zheng
Executive officer and director
JD
Jay Kranzler, M.D., Ph.D.
Executive officer and director
MW
Michael Weiss
Director
LD
Lindsay Rosenwald, M.D.
Director